Interferon alfa 2b - BIOFERON

Ready to use PFS containing Interferon Beta 1a for intramuscular injection. Each PFS contains interferon Beta 1a 30 µg 

Freeze dried vials containing 1K IU, 2K IU, 3K IU, 4K IU, 10 K IU; 20K IU; 40K IU

SOLUTION FOR INJECTION. Vials containing filgrastim 300 µg (30 M IU) or 480 µg (48 M IU)

Freeze dried powder for reconstitution containint Somatropin 4 IU or Somatropin 16 IU

Single use vial ampoule containing azacitidine 100 mg freeze dried powder for IV/SC infusion. Antineoplastic, DNA Methylation Inhibitor

Vial ampoule of freeze dried powder containing Bortezomib 3.5 mg for IV injection

Ready to use PFS containing Interferon Beta 1a. Each PFS contains interferon Beta 1a 22 µg (6 MIU) or 44 µg (12 MIU)

INTESTINAL PROBIOTIC

Cartridge containing 3 ml of a solution of 20 mg (60 UI) somatropin

Each Ready to use PFS contains Teriparatide 250 µg/mL

Azacitidine Drug of choice in adult patients who are not considered candidates for hematopoietic stem cell transplantation and who suffer from: myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. Each vial contains azacitidine 100 mg as a sterile lyophilized powder for ...

Blastoferon is a recombinant human interferon, produced by mammalian mass cell culture technology. Interferon beta 1a is indicated for the treatment of relapsing recurrent multiple sclerosis.
Blastoferon product is available as a pre-filled syringe solution ready for subcutaneous injection and comes in...

Todavía en etapa inicial, un equipo local, junto al Hospital de Clínicas y la Facultad de Medicina de la UBA, comienza la fase de ensayo exploratorio de una tecnología inhalable para tratar el coronavirus, en cualquiera de sus variantes

Las empresas argentinas ProinVet Innovations y Biosidus trabajan conjuntamente en una terapia inhalatoria para enfrentar el COVID-19

Institutional video that shows our state of the art production facilities and processes performed at Biosidus in Buenos Aires, Argentina